Caribou Biosciences (CRBU) EBITDA Margin (QoQ) (2020 - 2026)
Caribou Biosciences (CRBU) EBITDA Margin (QoQ) (2020 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - |
| 10 | Caribou Biosciences | 156.25 Mn | 38.63 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -37,440.00 |
| Dec 31, 2025 | 61,561.00 |
| Sep 30, 2025 | 44,637.00 |
| Jun 30, 2025 | 3,980.00 |
| Mar 31, 2025 | 4,793.00 |
| Dec 31, 2024 | 1,754.00 |
| Sep 30, 2024 | -63,343.00 |
| Jun 30, 2024 | 63,806.00 |
| Mar 31, 2024 | -84,153.00 |
| Dec 31, 2023 | -99,049.00 |
| Sep 30, 2023 | 81,347.00 |
| Jun 30, 2023 | 1,321.00 |
| Mar 31, 2023 | -6,030.00 |
| Dec 31, 2022 | -2,480.00 |
| Sep 30, 2022 | -12,520.00 |
| Jun 30, 2022 | 10,455.00 |
| Mar 31, 2022 | 1,461.00 |
| Dec 31, 2021 | -32,929.00 |
| Sep 30, 2021 | 61,348.00 |
| Jun 30, 2021 | -25,087.00 |